Neuroservices-Alliance

Neuroservices-Alliance

Paris, France· Est.
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Total funding raised: $2.8M

Overview

Neuroservices-Alliance is a Paris-based, privately-held CRO founded in 2010, focused exclusively on the challenging field of CNS and pain research. It operates as a 'one-stop shop,' providing integrated services from cell-based assays to complex in vivo models, leveraging techniques like patch-clamp, MEA, calcium imaging, and work with human-derived neural organoids. The company's value proposition centers on deep scientific expertise, high-quality reproducible data, and interactive client support throughout the study lifecycle. It serves pharmaceutical and biotech clients, generating revenue through fee-for-service contracts.

NeurosciencePain

Technology Platform

Integrated suite of electrophysiology and neuropharmacology platforms including Cell Electrophysiology (patch-clamp), Human & Rodent Neural Organoids, Ex Vivo Brain Slice recordings, In Vivo Brain Electrophysiology (LFP/EEG/optogenetics), and In Vivo Spinal Cord/DRG recordings, complemented by Calcium Imaging and MEA.

Funding History

2
Total raised:$2.8M
Seed$2M
Grant$800K

Opportunities

Growing investment in CNS drug discovery against high unmet need creates sustained demand for specialized preclinical services.
The industry's shift towards more translational, human-relevant models (e.g., organoids) plays directly into the company's advanced platform strengths.
Potential to expand service offerings into data analytics and computational neuroscience.

Risk Factors

Revenue is tied to volatile biopharma R&D budgets, particularly in the high-risk CNS space.
Faces competition from other specialized CROs, academic cores, and large full-service CROs.
Requires continuous capital investment to maintain technological edge and operational excellence in complex, project-based science.

Competitive Landscape

Competes in the niche of neuroscience-focused CROs. Differentiates through a comprehensive, integrated 'one-stop-shop' approach spanning from cells to in vivo models, with a specific emphasis on high-content electrophysiology and human-derived organoid models. Must compete on scientific expertise, data quality, and client collaboration against both other specialists and broader preclinical CROs.